A study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found that Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups—including white or Latino men—despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.
The White House has established an initiative that aims to help federal agencies, companies, and philanthropic groups to close research gaps in women’s health care—including cancer.
Led by Lyor Cohen, global head of music at YouTube and Google, City of Hope raised more than $4.3 million at its Music, Film and Entertainment Industry fundraising group’s Spirit of Life gala.
Researchers at Keck School of Medicine of USC and USC Norris Comprehensive Cancer Center uncovered racial bias leading to recommended therapy being rejected and to delays in care, diagnosis.
At a Senate hearing that considered her nomination to the post of NIH director, Monica Bertagnolli laid out an agenda that includes expanding access to clinical trials and making health care innovation affordable and accessible to the public.
Amid the gridlock that has seized Washington, NCI faces a grim and disturbing FY2024, the institute’s Principal Deputy Director Douglas R. Lowy said at the annual meeting of the Association of American Cancer Institutes.
As Robert A. Winn begins his two-year term as president of the Association of American Cancer Institutes, his presidential initiative of “Inclusive Excellence” aims to increase collaboration among cancer centers, their communities, and other cancer organizations in the United States and abroad.
At a time of intensifying national polarization over critical race theory and affirmative action, leaders of cancer centers are faced with two challenges that appear to be diametrically at odds with each other
A $10.9 million grant from the National Institutes of Health will help establish the University of Hawaiʻi Pacific Center for Genome Research.
Results from a collaborative study on universal hereditary cancer genetic testing in all patients with breast cancer in a rural population in the Annals of Surgical Oncology. Conducted by Invitae in collaboration with The Outer Banks Hospital in North Carolina from 2019 to 2022, the study analyzed the implementation of universal hereditary cancer genetic testing in all patients with breast cancer, as recommended by the American Society of Breast Surgeons guidelines in 2019.
